Tag: Irukandji Syndrome antidote
Phebra to spearhead clinical trial for Irukandji Syndrome antidote
Australian pharmaceutical company Phebra in collaboration with distinguished experts from around North Queensland will be working on a new clinical trial to test the...
Featured Article
Xometry CEO Sanjeev Singh Sahni on how AI and digital networks are reshaping manufacturing supply chains
Australian manufacturers have long competed against distance. In an exclusive interview with Australian Manufacturing, Xometry CEO Sanjeev Singh Sahni discusses how AI can help manufacturers access more production capacity and simplify traditionally email-driven supply chains.
